BK60106

• UNSPSC Description :

  BK60106 is a CD99 inhibitor that directly binds to the extracellular domain of CD99. BK60106 selectively kill Ewing sarcoma (ES) cells. BK60106 induces apoptosis in ES cells with less DNA damage[1].

• Target Antigen :

  Apoptosis

• Type :

  Reference compound

• Related Pathways :

  Apoptosis

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/bk60106.html

• Solubility :

  10 mM in DMSO

• Smiles :

  NC1=NC(C2=NC=CC=C2)=NC3=C1N=CN3[C@@H]4O[C@H](CO)[C@@H](O)[C@@H]4F

• Molecular Weight :

  346.32

• References & Citations :

  [1]Kaluvu Balaraman, et al. Design, synthesis and biological evaluation of Nucleosidic CD99 inhibitors that selectively reduce Ewing sarcoma viability. Eur J Med Chem. 2023 May 5;251:115244.

• Shipping Conditions :

  Room temperature

• Clinical Information :

  No Development Reported